Todd Watanabe

See Remarks, Director, Arcutis Biotherapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$3.4M

Companies

Latest trade

Aug 3, 2026

Companies

Arcutis Biotherapeutics, Inc.See Remarks, Director −$5.3M

Trades

ARQT Sold 4,375 shares at $26.12 · planned $0.1M Aug 3

ARQT Sold 3,172 shares at $23.61 · planned $0.1M May 4

ARQT Sold 37,349 shares at $25.18 · planned $0.9M Mar 2

ARQT Sold 19,833 shares at $25.50 · planned $0.5M Feb 2

ARQT Sold 48,945 shares at $30.36 · planned $1.5M Nov 24

ARQT Sold 1,055 shares at $30.00 · planned $0.0M Nov 21

ARQT Sold 11,547 shares at $24.71 · planned $0.3M Nov 3

ARQT Sold 40,000 shares at $25.03 · planned $1.0M Oct 28

ARQT Sold 20,739 shares at $20.04 · planned $0.4M Oct 2

ARQT Sold 24,261 shares at $19.33 · planned $0.5M Oct 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.